NYSE:CO Global Cord Blood (CO) Stock Price, News & Analysis $1.45 0.00 (0.00%) As of 07/2/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock About Global Cord Blood Stock (NYSE:CO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Global Cord Blood alerts:Sign Up Key Stats Today's Range$1.45▼$1.4550-Day Range$0.55▼$1.5052-Week Range$2.03▼$5.50VolumeN/AAverage Volume216,519 shsMarket Capitalization$176.25 millionP/E Ratio2.27Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong. Read More Receive CO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address CO Stock News HeadlinesBlood Market Trends and Outlook 2025-2029: Trends and Opportunities in Therapeutic, Diagnostic, and R&D ApplicationsJuly 3 at 6:11 AM | uk.finance.yahoo.comThinking about cord blood banking? Here's the difference between private and public banksJune 26, 2025 | msn.comHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing to invest in new "E.I." Tech, which one expert estimates will grow by 200,000%. Becoming bigger than the automobile, PC, and cell phone markets... COMBINED!July 4 at 2:00 AM | Behind the Markets (Ad)Atlantis Logistics Expands Global Operations Under CEO Rick Kerawala with Launch of Mumbai OfficeMay 7, 2025 | finance.yahoo.comUmbilical cord could contain clues for child's future health, study saysApril 25, 2025 | msn.comBreakthrough stem cell therapy opens new treatment paths for autoimmune patientsApril 17, 2025 | reuters.comUAE families can now store baby's cord blood at half the price in new Abu Dhabi biobankApril 1, 2025 | msn.comExperimental blood test accurately indicates severity and predicts potential recovery from spinal cord injuryMarch 31, 2025 | msn.comSee More Headlines CO Stock Analysis - Frequently Asked Questions How have CO shares performed this year? Global Cord Blood's stock was trading at $1.50 at the start of the year. Since then, CO shares have decreased by 3.3% and is now trading at $1.45. How were Global Cord Blood's earnings last quarter? Global Cord Blood Co. (NYSE:CO) issued its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company earned $37.14 million during the quarter. How do I buy shares of Global Cord Blood? Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Global Cord Blood own? Based on aggregate information from My MarketBeat watchlists, some other companies that Global Cord Blood investors own include Micron Technology (MU), Dynavax Technologies (DVAX), AT&T (T), Vale (VALE), Cisco Systems (CSCO), Pfizer (PFE) and United Microelectronics (UMC). Company Calendar Last Earnings6/26/2018Today7/04/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:CO CIK1467808 Webwww.globalcordbloodcorp.com Phone(523) 605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio2.27 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.24 billion Price / Sales0.14 Cash Flow$0.35 per share Price / Cash Flow4.19 Book Value$6.34 per share Price / Book0.23Miscellaneous Outstanding Shares121,551,000Free FloatN/AMarket Cap$176.25 million OptionableNo Data Beta0.16 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NYSE:CO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.